Daiwa Securities Group Inc. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 387 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$25
+31.6%
4690.0%0.00%
Q1 2024$19
-5.0%
469
-13.1%
0.00%
Q4 2023$20
+11.1%
540
+13.9%
0.00%
Q3 2023$18
+5.9%
4740.0%0.00%
Q2 2023$17
-19.0%
474
-12.9%
0.00%
Q1 2023$21
-32.3%
5440.0%0.00%
Q4 2022$31
-99.8%
544
+5.8%
0.00%
Q3 2022$20,000
-13.0%
5140.0%0.00%
Q2 2022$23,000
+43.8%
514
+25.1%
0.00%
Q1 2022$16,000
-5.9%
4110.0%0.00%
Q4 2021$17,000
-15.0%
411
-15.6%
0.00%
Q3 2021$20,000
+66.7%
487
+81.7%
0.00%
Q2 2021$12,000
+9.1%
2680.0%0.00%
Q1 2021$11,0000.0%268
+5.5%
0.00%
Q4 2020$11,000
-45.0%
254
-67.0%
0.00%
Q3 2020$20,000
+42.9%
7690.0%0.00%
Q2 2020$14,0000.0%7690.0%0.00%
Q1 2020$14,000
-6.7%
769
-7.0%
0.00%
Q4 2019$15,000
+7.1%
827
-10.3%
0.00%
Q3 2019$14,000
-12.5%
9220.0%0.00%
Q2 2019$16,000
+6.7%
9220.0%0.00%
Q1 2019$15,000
+25.0%
922
+17.2%
0.00%
Q4 2018$12,000
-14.3%
7870.0%0.00%
Q3 2018$14,000
+7.7%
7870.0%0.00%
Q2 2018$13,000
-13.3%
7870.0%0.00%
Q1 2018$15,0007870.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$206,177,00028.12%
BB BIOTECH AG 8,322,860$121,763,0003.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 398,633$4,579,0002.84%
DOHENY ASSET MANAGEMENT /CA 227,193$3,324,0002.43%
SNYDER CAPITAL MANAGEMENT L P 2,833,759$41,458,0002.24%
First Light Asset Management, LLC 938,399$13,729,0002.19%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,027,164$132,067,0001.77%
Taylor Wealth Management Partners 204,277$2,989,0001.72%
Sterling Global Strategies LLC 22,000$321,860,0001.63%
Granite Investment Partners, LLC 988,939$14,468,0001.06%
View complete list of HALOZYME THERAPEUTICS INC shareholders